|Bid||173.94 x 1100|
|Ask||174.04 x 800|
|Day's Range||173.90 - 175.98|
|52 Week Range||114.04 - 182.55|
|Beta (5Y Monthly)||0.94|
|PE Ratio (TTM)||20.43|
|Earnings Date||Jan 26, 2021|
|Forward Dividend & Yield||5.88 (3.32%)|
|Ex-Dividend Date||Nov 19, 2020|
|1y Target Est||173.44|
3M Health Information Systems teams with Rad AI to offer integrated technologies for radiology reporting, with joint workflow featured at RSNA 2020.
The case for buying 3M (NYSE: MMM) is a value-investing one. In a nutshell, you aren't buying 3M for what it is now, but rather for what it could become if CEO Mike Roman's restructuring begins to generate operational improvements and its end markets start to improve.
Among the thousands of dividend-paying stocks out there, only around 65 are featured on the list of Dividend Aristocrats today. Not surprisingly, Dividend Aristocrats can be excellent sources of steady, passive income. Known for Post-It Notes and Scotch tapes, 3M (NYSE: MMM) is, in reality, a megaconglomerate with nearly 60,000 products under its belt and sales in nearly every corner of the world.